Improvement of Sexual Function in Testosterone Deficient Men Treated for 1 Year with a Permeation Enhanced Testosterone Transdermal System
The Journal of UrologyPublished 1 May 1996
Stefan Arver, Adrian S. Dobs, A.W. Meikle, Richard P. Allen, Steven W. Sanders, Norman A. Mazer
Citations159
SJR quartileQ1
SJR score2.21
SNIP2.70
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Sexual function improved significantly in men with hypogonadism treated with the testosterone transdermal system, and nocturnal erections occurred more frequently with longer duration and greater rigidity.
Abstract
PURPOSE: The effects of androgen replacement via a nonscrotal permeation enhanced testosterone transdermal system on the sexual function of men with hypogonadism were assessed. MATERIALS AND METHODS: An open label, multicenter study of testosterone supplementation and withdrawal was conducted with sexual function assessed by the Watts and Davidson questionnaires and RigiScan monitoring. RESULTS: When comparing results obtained during use of the testosterone transdermal system (with normalized testosterone levels) and during the androgen withdrawal period, nocturnal erections occurred more frequently with longer duration and greater rigidity, and patient assessments of sexual desire and weekly number of erections were higher. CONCLUSIONS: Sexual function improved significantly in men with hypogonadism treated with the testosterone transdermal system.
Keywords
PsychologyMedicine
The Journal of Clinical Endocrinology & MetabolismTestosterone Secretion and Metabolism in Male Senescence
537 Citations1972A. Vermeulen, R.D. Rubens +1 more
It was observed that plasma testosterone levels and the apparent free plasma testosterone concentration remain within the same range from adolescence until the age of 50 yr, but that from the 6th decade on, the mean plasma levels decrease rather rapidly, with a wide range of individual values.
The Journal of Clinical Endocrinology & MetabolismEffects of Androgen on Sexual Behavior in Hypogonadal Men
365 Citations1979Julian M. Davidson, Carlos A. Camargo +1 more
It is concluded that the stimulatory effects of testosterone on sexual activity are rapid, reliable, and not due to a placebo effect and to maintain plasma testosterone and adequate sexual function within normal levels, even high doses of testosterone enanthate should be given no less frequency than once every 3 weeks.
The Journal of Clinical Endocrinology & MetabolismThe Nature of Androgen Action on Male Sexuality: A Combined Laboratory-Self-Report Study on Hypogonadal Men*
346 Citations1983Marie Kwan, W Greenleaf +3 more
The data and previous findings lead to the conclusion that the major androgen action on male sexuality involves libido factors (i.e. sexual motivation/interest).
Clinical EndocrinologyANDROGEN REPLACEMENT WITH ORAL TESTOSTERONE UNDECANOATE IN HYPOGONADAL MEN: A DOUBLE BLIND CONTROLLED STUDY
339 Citations1981Niels E. Skakkebæk, John Bancroft +2 more
Sexual interest increased within the first week of T.U. administration, ejaculation usually returning within the second week, and behaviour responses were similar in the hyper‐ and hypogonadotrophic groups.
The Journal of Clinical Endocrinology & MetabolismTreatment of Male Hypogonadism with Testosterone Enanthate*
299 Citations1980Peter J. Snyder, David A. Lawrence
The close parallel of the FSH response to that of LH suggests that testosterone is the major physiological inhibitor of FSH as well as of LH, and several dosage regimens of testosterone enanthate appeared to be the most effective of those tested in terms of suppression of the serum LH concentration to normal and infrequency of administration.
Archives of Sexual BehaviorChanges in erectile responsiveness during androgen replacement therapy
294 Citations1983John Bancroft, F.C.W. Wu
Preliminary results suggest that erections to certain types of stimuli are relatively independent of androgens, whereas the response to fantasy may be androgen dependent.
Journal of AndrologyA Long‐term, Prospective Study of the Physiologic and Behavioral Effects of Hormone Replacement in Untreated Hypogonadal Men
266 Citations1992Allen S. Burris, Steven M. Banks +3 more
The hypothesis that androgen treatment increases nocturnal and spontaneous erections, and sexual interest, and has some capacity to improve mood is supported.
Clinical EndocrinologyANDROGENS, BEHAVIOUR AND NOCTURNAL ERECTION IN HYPOGONADAL MEN: THE EFFECTS OF VARYING THE REPLACEMENT DOSE
183 Citations1985Ronan E. O’Carroll, Colin M. Shapiro +1 more
The behavioural effects of varying the replacement dose of the oral androgen testosterone undecanoate (TU, Restandol) were investigated in eight hypogonadal men, finding sleep erections improved significantly during testosterone administration.
The Journal of Clinical Endocrinology & MetabolismEnhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.
176 Citations1992A.W. Meikle, Norman A. Mazer +5 more
The results indicate that the enhanced transdermal delivery of T across nonscrotal skin is a patient-friendly androgen replacement modality and produces physiological concentrations of T and its metabolites, which are unattainable with other treatment modalities.
The Journal of Clinical Endocrinology & MetabolismTestosterone Replacement Therapy and Sleep-Related Erections in Hypogonadal Men
144 Citations1990Glenn R. Cunningham, MAX HIRSHKOWITZ +2 more
Comparison of results to those in normal men revealed that none of these men met all diagnostic criteria for organic impotence, even 7-8 weeks after discontinuation of testosterone administration, which is useful for differentiating psychogenic from organic erectile dysfunction.
The LancetTRANSDERMAL TESTOSTERONE SUBSTITUTION THERAPY FOR MALE HYPOGONADISM
130 Citations1986M. Bals‐Pratsch, Yong‐Dal Yoon +2 more
TTS testosterone offers a new approach to androgen substitution therapy, and serum testosterone levels in normal men were moderately increased, with concentration curves almost parallel to basal levels.
Clinical EndocrinologyLong‐term efficacy and safety of a permeation‐enhanced testosterone transdermal system in hypogonadal men
128 Citations1997Stefan Arver, Adrian S. Dobs +5 more
This work has assessed hormone levels, pharmacokinetics and clinical response, including safety, of a permeation‐enhanced testosterone transdermal system (TTD) in the treatment of hypogonadal men for a 12‐month period.
The Journal of Clinical Endocrinology & MetabolismQuantitating Genetic and Nongenetic Factors Influencing Androgen Production and Clearance Rates in Men*
128 Citations1988A.W. Meikle, John D. Stringham +2 more
The results suggest that genetic factors markedly influence the PRs of testosterone and DHT, suggesting that the PR of these potent androgens is under genetic control despite the decided influence of environmental factors on their clearance.
Endocrinology and Metabolism Clinics of North AmericaHormonal Therapy of Male Hypogonadism
115 Citations1994Alvin M. Matsumoto
The goals of hormonal treatment of male hypogonadism depend upon the stage of sexual development in which gonadal failure occurs, and combined treatment with hCG plus hMG is needed to initiate sperm production and fertility.
The Journal of Clinical Endocrinology & MetabolismFurther Study of Factors Affecting the Metabolic Clearance Rate of Testosterone in Man<sup>1</sup>
93 Citations1968A. Louis Southren, Gary G. Gordon +1 more
A study of the effect of various factors on the metabolic clearance rate of testosterone (MCRT) found change from the supine to the erect position resulted in a sharp fall in the MCRT in one subject, with little or no significant change in 3 additional subjects.
The Journal of UrologyNocturnal Penile Tumescence and Rigidity in Men without Complaints of Erectile Dysfunction Using a New Quantitative Analysis Software
73 Citations1994Laurence A. Levine, Richard A. Carroll
Cumulative distributions of rigidity and tumescence activity units were developed to permit a simple, direct comparison of other nocturnal penile tumscence and rigidity findings to results in the study population.
Nursing ResearchSexual Functioning, Health Beliefs, and Compliance with High Blood Pressure Medications
64 Citations1982Rosalyn J. Watts
Sexual functioning in 84 hypertensive subjects enrolled in an inner city hypertensive program with a matched group of 84 nonhypertensive subjects attending ambulatory care was compared and self‐report compliance was significantly related to controlled DBP.
Nursing ResearchSexual Functioning, Health Beliefs, and Compliance with High Blood Pressure Medications
62 Citations1982Rosalyn J. Watts
UrologyHypogonadal impotence treated by transdermal testosterone
51 Citations1991R. Dale McClure, Raymond Oses +1 more
The transdermal therapeutic system for testosterone (TTS-T) (ALZA Corp.), applied to the scrotal skin for twenty-two hours daily, was tested for twelve weeks on 4 men with hypogonadal impotence, restoring normal erectile activity with an increased frequency of ejaculation and a positive effect on both mood and energy.
PsychoneuroendocrinologyPsychosexual behavior in hypopituitary men: A controlled comparison of gonadotropin and testosterone replacement
46 Citations1993Richard R. Clopper, Mary L. Voorhess +3 more
Journal of AndrologyQuantitative Assessment of Nocturnal Penile Tumescence and Rigidity In Normal Men Using a Home Monitor
42 Citations1989Allen S. Burris, Steven M. Banks +1 more
Assessment of NPTR in normal men using a portable, take-home monitor found that penile tumescence time was found to decrease with advancing age, whereas the number of erectile episodes and penile rigidity did not significantly change with age for men in the third through sixth decades.
Journal of Steroid BiochemistryEstradiol and testosterone metabolism and production in men with prostatic cancer
21 Citations1989A.W. Meikle, Joseph A. Smith +1 more
The results indicate that men with prostatic cancer have elevated clearance and production rates of testosterone without an alteration of estradiol production or clearance.